Closing the Generation Gap: Part 2 - Hemophilia Federation of America

Join us in a discussion as young adults and experienced members of the community share their knowledge with each other. This discussion is intended to “close the generation gap” and provide a space for community members, both younger and wiser, to share their perspectives and experiences with their bleeding disorder. Part 1 was a great […]
<!-- wp:paragraph --> <p>Join us in a discussion as young adults and experienced members of the community share their knowledge with each other. This discussion is intended to “close the generation gap” and provide a space for community members, both younger and wiser, to share their perspectives and experiences with their bleeding disorder.</p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p>Part 1 was a great success, and we can't wait for you to join us for part 2. </p> <!-- /wp:paragraph -->

Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A

A practical approach for adoption of a hub and spoke model for cell and gene therapies in low- and middle-income countries: framework and case studies

Working with Rare Disease Communities and Advocacy Groups

Prophylaxis and hemophilia care in LATAM: Baring it all—Highlights from the CLAHT 2021 symposium - DiMinno - 2022 - eJHaem - Wiley Online Library

Magnetic resonance imaging in boys with severe hemophilia A: Serial and end‐of‐study findings from the Canadian Hemophilia Primary Prophylaxis Study - ScienceDirect

Core Concepts - HIV in Infants and Children - Key Populations - National HIV Curriculum

Closing the Generation Gap: Part 2 - Hemophilia Federation of America

Abstracts - 2022 - Haemophilia - Wiley Online Library

Federal 340B Leader Moves On After 21 Months - 340B Report

Frontiers Fragile sites, chromosomal lesions, tandem repeats, and disease

National Haemophilia No 217 March 2022 by Haemophilia Foundation Australia - Issuu

Closing the gap in a generation: Health equity through action on the social determinants of health - PAHO/WHO

Why are haemophilia gene therapies so expensive? - Pharmaceutical Technology

Federal Register :: Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2024

New Patient Journey Infographic Gives A Glimpse Into The Diagnostic Odyssey - National Organization for Rare Disorders